chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first 24 hours: fever, fatigue, headache, body ache; Body rash from neck down to groin including A-P trunk; mild under-eye swelling; first 24 hours: fever; first 24 hours: fever, fatigue; first 24 hours: fever, fatigue, headache; This is a spontaneous report from a non-contactable healthcare professional. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0150) via an unspecified route of administration in the left arm on 16Apr2021 at 14:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient had unspecified medical history. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient received unspecified medications within two weeks of the vaccination. On 17Apr2021, in first 24 hours, the patient experienced  fever, fatigue and headache. On 18Apr2021, 2 days after vaccination, the patient experienced body ache, body rash from neck down to groin including A-P trunk, ongoing headache and fatigue, mild under-eye swelling and these symptoms are ongoing and unresolved at that time. The adverse event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. It was unknown whether the patient received any treatment for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, fatigue, headache, body ache, body rash from neck down to groin including A-P trunk and mild under-eye swelling was not recovered at the time of this report.    No follow-up attempts are possible. No further information is expected.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed chickenpox. It was reported that 2 of her children subsequently developed chickenpox.
low grade fever, progressive pain in the arm from injection site to the elbow; loss of appetite, general feeling of illness for about a week and a half. Tx: steroids, tramadol, aleve, icing
Finger pain; COVID vaccine issue Low grade temperature; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (COVID vaccine issue Low grade temperature) and PAIN IN EXTREMITY (Finger pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis and COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 07-Apr-2021, the patient received first dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) citrate free. In 2021, the patient experienced PYREXIA (COVID vaccine issue Low grade temperature). On an unknown date, the patient experienced PAIN IN EXTREMITY (Finger pain). At the time of the report, PYREXIA (COVID vaccine issue Low grade temperature) and PAIN IN EXTREMITY (Finger pain) outcome was unknown.            Concomitant products were not provided. Treatment medications were not reported.
I had fever, muscle aches, cramps, diarrhea, cough, runny nose. I lost taste for a little bit of time. The cough lasted for 2.5 months. The fever which got up to 104 degrees and rest of the symptoms lasted for a week.
This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-APR-2021, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), lot # T039454, and expiration date since it makes match with the auto-populated expiration date 14-DEC-2021) (dose, route of administration and anatomical location were not reported) for prophylaxis. Administered dose of vaccine was stored in the temperature of 9 degrees Celsius for 10 hours and 56 minutes. There were no previous temperature excursions reported. The improper storage was recorded by digital data logger. There was no additional adverse event reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2104USA003768.
Marked swelling entire (L) upper arm with erythema, warmth, tenderness. Nonfocal to injection site.
Healthy child - 3 mo post shot, simple infection triggered non-typical autoimmune response that intensified over the next 18 months.  Stomach pain, headache/migraine, sensitivity to light, extreme fatigue, nausea, unsteadiness, concentration problems, clogged lymphatics.  Condition worsened saw GI & pain specialists, Hospitalized 2x, entered pediatric pain program. Problems focused around GI Track, Autoimmune & neurological issues) Drs. explored possible diagnosis (Functional Abdominal Pain, Visceral Hyperalgesia, Parasites, Mono, Dysautonomia, CRPS, PCOS.  Appears vaccine may have "woke up" her autoimmune system and affected its reactions to infections, Epstein Barr, parasites & food sensitivities. Over last 5 years, pain & symptoms ebbed and flowed typically trigged by infection. Aggressive support of Methylaton Cycle and detox & supplements improved c
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 01-MAY-2018, the patient was vaccinated with an improperly stored dose of LIQUID PEDVAXHIB, lot # N022167, expiration date: 08-FEB-2020 (dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 47 to 77 degrees Fahrenheit for 5 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1806USA001505: US-009507513-1806USA009026: US-009507513-1806USA009027: US-009507513-1806USA009028: US-009507513-1806USA009029: US-009507513-1806USA009030: US-009507513-1806USA009031: US-009507513-1806USA009032: US-009507513-1806USA009034: US-009507513-1806USA009035: US-009507513-1806USA009036: US-009507513-1806USA009037: US-009507513-1806USA009038: US-009507513-1806USA009039: US-009507513-1806USA009040: US-009507513-1806USA009041: US-009507513-1806USA009042: US-009507513-1806USA009043: US-009507513-1806USA009044: US-009507513-1806USA009045: US-009507513-1806USA009046: US-009507513-1806USA009047: US-009507513-1806USA009048: US-009507513-1806USA009049: US-009507513-1806USA009050: US-009507513-1806USA009051: US-009507513-1806USA009052: US-009507513-1806USA009053: US-009507513-1806USA009054: US-009507513-1806USA009055: US-009507513-1806USA009056:
This spontaneous report was received from a Registered Nurse regarding an unspecified number of patients of unknown demographics. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored PROQUAD, lot# L016394, expiration date- 08-NOV-2016. No concomitant medication was reported. No adverse event was reported. The outcome of the event was unknown. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Nose bleed; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 25Apr2021 at 15:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included Lyme disease diagnosed 8 years ago in 2013. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 26Apr2021 at 9:30, the patient experienced nose bleed which lasted for 1 hour. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nose bleed was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Approximately 24 hrs after receiving my 2nd COVID Vaccine, I experienced swelling and tenderness in the underarm area. As of Monday, it is slightly less tender and swollen but still has tenderness.
Arm really and then the next day, 8/8, it was very swollen and hurt. Went Sunday afternoon to ER to have checked. Gave something for pain and nausea.
As per mom right thigh became itchy, red and warm to touch.  No pain per pt.
3RD DOSE MODERNA COVID VACCINE GIVEN 9/16/21, LOT # NOT AVAILABLE; 4TH DOSE MODERNA COVID VACCINE GIVEN 11/17/21, #069F21A; 5TH DOSE MODERNA COVID VACCINE GIVEN 7/26/22, #038A22A; pt down and home and unresponsive, not breathing; EMS called; CPR x15 mins before ROSC; taken to ED; (pt diagnosed with COVID 4 days earlier); intubated; poor prognosis; myoclonic jerking; family decided to withdraw care and pursue comfort measures; pt passed away in the hospital ED
Reports left pupil dilated 60" after injection.  Went to ophth - resolved with PILOCORPINE & sent to ED for neuro work up CT, CTA work up was inconclusive.
Pt states that at 11:13 her right hand started feeling tight. Pt stated she had the vaccine administered in her left arm. Pt's Vitals are stable. Stroke scale negative. Positive CMS in extremities. Pt was cleared to go home by onsite Doctor.
Headache initially. On 1/15: severe headache, chills, 101.5 fever, joint pain, body aches, non-productive cough, runny nose
(L) arm swelling at vaccine site began within 12 hrs. No erythema rash. 6cm swelling and induration. Pt Tx with CLARITIN and ice, ASA, Ibu, TYLENOL. No SOB. Neck sore. Feverish
The name of the vaccine was Trivalent High-Dose 2:00 (ish) - flu shot Ate a light lunch (1/2 sandwich) around 3:00 Had 1/2 beer and some almonds around 5:15 5:45 - stabbing pain in upper abdomen, nausea (no vomiting) 6:15 (ish) - pain seemingly moving from injection site to right side of body, exhausted, had to lie down. Chills, low fever (99.5). Couldn't move to get more blankets. Heart starts racing (could have been a panic attack), took 1/4 mg of xanax . Mild  delirium. For the next 8 hours, imagined the pain as a video game board that I was 'clearing' - the pain in the area would lessen each time I 'cleared' it.  2:30 AM - finally able to fall asleep, fever at 100.5 5:00 AM - fever breaks, able to get up for water 6:00 - 11:00 AM  - sleep, listless and fatigued the rest of the day
Vaccine expired on 03-Oct-2021/ refrigerated on 04-Nov-2021/ administered on 23-Nov-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021/ refrigerated on 04-Nov-2021/ administered on 23-Nov-2021) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021/ refrigerated on 04-Nov-2021/ administered on 23-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine expired on 03-Oct-2021/ refrigerated on 04-Nov-2021/ administered on 23-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The healthcare professional (HCP) wanted to know about the protocol for this situation and whether the doses were viable or not. HCP said that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  There was no temperature excursion and the patient did not experienced any adverse event.  The vaccine was place in the refrigerator on 04 Nov 2021.  No treatment medications were reported.
Felt sick; hives; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt sick) and URTICARIA (hives) in a 28-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (Patient was diagnosed with Covid 19) in 2020.  On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Felt sick) and URTICARIA (hives). At the time of the report, ILLNESS (Felt sick) outcome was unknown and URTICARIA (hives) had resolved with sequelae.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2020, SARS-CoV-2 test: Positive.  Concomitant product use was not provided by the reporter.  The patient felt sick, had hives when she received the Moderna covid booster. She said she could get hives very easily. It was unknown if the patient experienced any additional symptoms/events.   Medication Details and reason for taking the medicine: Rest.  Treatment information was not provided.
Patient felt pain in her arm for a few days, and her back started to hurt. No fever or joint pain. On 7/30/19, patient came into the pharmacy and showed her arm to the pharmacist. She did get an injection site reaction and there was redness and a little swelling around the injection site  (about 6 inches long and 3 inches wide). She did not complain of itchiness or severe pain. Pharmacist suggested cold compresses and a benadryl. Advised her to wait a few days to see if the injection site got better. It it doesn't get better, advised her to see her doctor.
In the pt's words " received our second covid-19 vaccination on Sunday. I got my vaccination about 10:00. By 8:00 PM I was not feeling well. Had all of the side effects, chills, fever, muscle aches, joint pain and a wicked headache. Monday was the same minus the headache. Today, still have joint pain and feel very weak. The nurse that gave us our vaccinations said that if we experienced any of the side effects, we should let our primary physician know.  Hopefully all of this is normal and I will be back to my normal self soon. I am concerned because most of the information I have read says 24 hours and effects should be gone. Not so with me. Hope all is well with you and your family.  "  Spoke w/ pt on phone and she stated her s/s are subsiding, other than the arthralgia, RN
Dizzy and lightheaded 40 min after injection. Within 24 hours severe chills and fatigue, light headed, headaches, irregular heartbeat, ears ache, chest pain and shortness of breath. 8 days later was onset in severe vertigo.  2 days after second dose was moderate vertigo and mild fever.
patient was positive with covid-19 after the first dose; patient was positive with covid-19 after the first dose; This is a spontaneous report from a Pfizer-sponsored program by a contactable consumer (patient).  This 38-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot# EL1284), via an unspecified route of administration at single dose on 06Jan2021 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported.   The patient was positive with Covid-19 after the first dose in Jan2021 with outcome of unknown. The patient underwent lab tests and procedures which included sars-cov-2 test: positive in Jan2021. The event was described as follows: She received the first dose of Covid-19 vaccine on 06Jan2021. She had mild symptoms after receiving the vaccine. Since receiving the first dose she contracted Covid. She has completed her quarantine period. She was due to receive the second dose last Monday. The county health department does not recommend that she receive the second dose since she has the natural antibodies and she will have to wait 90 days to get the second dose. Her doctor says she needs to get the second dose. What is Pfizer's position as far as waiting since she tested positive for Covid? She barely experienced symptoms.
My tongue itches, burns and is tender to cold and touch. It lasts for 2 days, then goes away for a few days, but comes back.
like a cord from the swollen lymph node extending to the side of her breast; big lump on her left armpit/swollen lymph node; felt very tired; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (felt very tired), LYMPHADENOPATHY (big lump on her left armpit/swollen lymph node) and LYMPHADENOPATHY (like a cord from the swollen lymph node extending to the side of her breast) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced FATIGUE (felt very tired). On 26-Jan-2021, the patient experienced LYMPHADENOPATHY (big lump on her left armpit/swollen lymph node). On 02-Feb-2021, the patient experienced LYMPHADENOPATHY (like a cord from the swollen lymph node extending to the side of her breast). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Tiredness, at an unspecified dose and frequency. On 23-Jan-2021, FATIGUE (felt very tired) had resolved. At the time of the report, LYMPHADENOPATHY (big lump on her left armpit/swollen lymph node) was resolving and LYMPHADENOPATHY (like a cord from the swollen lymph node extending to the side of her breast) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitation medication provided
Chronic hives, allergic skin reaction in multiple locations; hands, feet, legs, breast, back etc
Pain Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Pain Injection Site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INJECTION SITE PAIN (Pain Injection Site). On 13-Feb-2021, INJECTION SITE PAIN (Pain Injection Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
She got her vaccine at 10:00 AM, her sister, her husband herself got it at the same time.  They went home, she drank water and to rotate the arm, which she did.  She sat down and ate something, and started doing work.  Her right foot was feeling a little tight and thought she needed to elevate it, but was limping a little bit.  At around 6:00 PM she decided to go to bed, and looked at her feet as it was getting worse.  She then had diarrhea and before going to the restroom her feet were swollen, her knees were swollen and her legs looked like they had swollen in the middle and they were joined together, which they never touched before.  She was getting worried and when she came out of the restroom, and saw that the nodules had gone down.  She drank a lot of water, and didn't sleep until 2:00 AM.  She got up this morning, came downstairs and got her computer together, ate something, and also started feeling tightness in her legs again.  She looked at her legs and noticed that they were swollen, but not as bad as yesterday.  Both legs yesterday were swollen and numb, and her toes were also.  She started wiggling her toes and her sister told her to go to the hospital, but she did not feel it was serious.  She did feel a little woozy and today is not as bad as yesterday, but she can feel the swelling coming back in her thighs as the day progresses.  She is a little tired, but did a COVID test and was negative.    She has been a little short of breath, but after she goes and lies down it goes away.  She has not called her doctor yet, but was trying to wait to see if the symptoms were getting better.
Recurrence of swollen, red itchy arm on day 3 and day 12 following vaccine
Minor hives on upper back 3 weeks after round 1.  Resolved before receiving round 2. Rash came back with a vengeance round 2. Rash was shingle like in patches on upper back.  Rash then extended to patch on lower back.  It was itching and burning and had papules.  Rash spread to area around umbilicus. Rash extended to spots down left arm. Went to physician on 02/15/2021.  Unsure if shingles or reaction to vaccine.  Prescribed a steroid shot and Zyrtec daily.  Prescribed Valacyclovir.
Within 1-2 hours post vax, pt became pale, fussy, clammy per mom. Slightly warm to touch, no temperature taken. Ate normally, slept well (? more than usual). Tylenol not effective. Initial dose inadequate, increased dose, still not helpful. Four phone calls with same concerns. Brought into office for evaluation 03/24/2000. Pt unremarkable except fussy but consolable, chewing on teether. Four upper incisor erupting. One cm induration at site.
Patient came in Saturday to show the rph her arm after she received first shingrix vaccine on Wednesday morning.  Her arm appear red and warm to the touch. She reported that it has been getting worse since Wednesday. I instructed the patient to go to urgent care because it appears to be cellulitis. Also of note, the vaccine seemed to be given to low in the arm.
chills; tonsillitis/tonsils were inflamed; uvulitis/uvula were inflamed; body malaise; This is a spontaneous report from a contactable nurse (patient).  A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EH9899, then intramuscular on left arm from 06Jan2021 08:15 to 06Jan2021 08:15 as SINGLE DOSE for COVID-19 immunisation.  Medical history included eczema.  Historical Vaccine includes: first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 16Dec2020 09:15. Concomitant medication included halobetasol propionate 0.05% ointment. On 07Jan2021, experienced body malaise (after 24 hours of receiving vaccine). On 08Jan2021, the patient experienced uvulitis, tonsillitis (after 48 hours of receiving the vaccine). The patient suddenly woke up from sleep feeling something was in his throat. Looked in the mirror and my uvula & tonsils were inflamed. On 08Jan2021, 08:00am, the patient experienced chills. No other symptoms accompanying the swelling of tonsils, uvula. The patient underwent nasal swab, L UMIRADX SARS-COV-2 AG test on 21Dec2020 with negative result. The outcome of the events was recovering at the time of the report. No treatment was given for the events.